RSS
|
|
|
Created in 1981, Galderma is a joint venture between Nestlé and L'Oréal. Galderma employs more than 3,200 people and is headed by President & CEO Humberto C. Antunes. The company has wholly owned affiliates in thirty-one countries and a worldwide network of sales agents. The parent company is based in Lausanne, Switzerland, with Corporate Services in Paris-La Défense, France. Galderma spends approximately 20% of its revenues in research and development at three sites: * Princeton New Jersey, USA (clinical development), * Tokyo Japan (clinical development). * Sophia Antipolis France (research and development, 500 people). Galderma runs three production facilities: * The Alby-sur-Chéran plant in the Haute-Savoie region of the French Alps opened in 1994. The plant currently delivers close to 30 million units per year to over seventy countries. Located at the same site, the industrial development unit takes new products from the lab to full industrial-scale production. * The Montreal plant in Canada started production in 2000 to meet the growing demand of the U.S. market. It has a capacity of 40 million units. * Lastly, Hortolândia (state of São Paulo) in Brazil, serves the regional markets. Galderma SA acquired AB, a pharmaceutical device company based in Uppsala, Sweden, in March 2011. Q-Med AB produces Restylane, Perlane, Macrolane, Deflux, Durolane and Solesta. Category:Pharmaceutical companies of Switzerland Category:L'Oréal Category:Nestlé de:Galderma fr:Galderma pt:Galderma |
